Literature DB >> 2796609

Corticosterone's dual metabolic actions.

L Devenport1, A Knehans, A Sundstrom, T Thomas.   

Abstract

Corticosterone possesses two distinctly opposite metabolic actions. The actions are strictly dose-dependent and are linked to type I and type II corticosteroid receptor binding. These conclusions are drawn from continuous infusion studies where corticosterone yields a bitonic dose-response curve for body weight gain and feeding efficiency. Anabolic at low serum levels, corticosterone concentrations above 2 micrograms/dl bring about an opponent catabolic process that intensifies and eventually masks the anabolic action. Relatively pure type I (aldosterone) and type II (RU28362 and dexamethasone) corticosterone receptor agonists produce opposite monotonic functions that respectively mimic the ascending and descending arms of the corticosterone dose-response curve. Stimulation of either receptor increases the proportion of carcass fat to lean body mass by either increasing carcass lipids (type I) or by reducing protein (type II).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2796609     DOI: 10.1016/0024-3205(89)90026-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 2.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 3.  Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.

Authors:  F Brambilla
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

5.  Glucocorticoids decrease body weight and food intake and inhibit appetite regulatory peptide expression in the hypothalamus of rats.

Authors:  Xiao-Yan Liu; Jian-Hua Shi; Wen-Hua DU; Yan-Ping Fan; Xiao-Lei Hu; Chen-Chen Zhang; Huan-Bai Xu; Yan-Jun Miao; Hai-Yan Zhou; Ping Xiang; Feng-Ling Chen
Journal:  Exp Ther Med       Date:  2011-06-21       Impact factor: 2.447

6.  Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.

Authors:  D N Brindley; P Hales; A I al-Sieni; J C Russell
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 7.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

8.  Corticosterone in thin-billed prion Pachyptila belcheri chicks: diel rhythm, timing of fledging and nutritional stress.

Authors:  Petra Quillfeldt; Maud Poisbleau; Olivier Chastel; Juan F Masello
Journal:  Naturwissenschaften       Date:  2007-06-14

Review 9.  Novel aspects of glucocorticoid actions.

Authors:  E T Uchoa; G Aguilera; J P Herman; J L Fiedler; T Deak; M B C de Sousa
Journal:  J Neuroendocrinol       Date:  2014-09       Impact factor: 3.627

10.  Catabolic effect of dexamethasone in the preterm baby.

Authors:  K G Brownlee; P C Ng; M J Henderson; M Smith; J H Green; P R Dear
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.